Lundbeck
HLUN-B.CO
#2346
Rank
€5.89 B
Marketcap
6,10 €
Share price
0.98%
Change (1 day)
21.29%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): 0,34 €

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is 0,32 €. In 2022 the company made an earnings per share (EPS) of 0,24 € a decrease over its 2021 EPS that were of 0,55 €.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,34 €38.01%
20220,24 €-55.47%
20210,55 €-51.83%
20201,13 €-28.01%
20191,57 €-44.08%
20182,81 €51.94%
20171,85 €126.64%
20160,82 €-120.84%
2015-3,92 €5622.18%
2014-0,06846 €-110.03%
20130,68 €-28.08%
20120,95 €-52.1%
20111,98 €-1.31%
20102,01 €15.61%
20091,74 €